Literature DB >> 9421899

Development and verification of fingerprinting probes for Candida glabrata.

Shawn R Lockhart1, Sophie Joly1, Claude Pujol1, Jack D Sobel1, Michael A Pfaller2, David R Sol1.   

Abstract

Since Candida glabrata has emerged as one of the most common Candida pathogens, DNA probes have been developed which fulfil the requirements for effective fingerprinting. Using a screen for complex genomic fragments containing moderately repetitive sequences, seven DNA probes were cloned which generate complex Southern blot hybridization patterns with EcoRI-digested C. glabrata DNA. All of the probes are species-specific and the majority cross-hybridize to varying degrees. The capacity of two of the probes, Cg6 and Cg12, to measure genetic distance between independent isolates is verified by comparing clustering in dendrograms based on similarity coefficients computed between all pairs of 39 independent isolates fingerprinted with Cg6, Cg12 and randomly amplified polymorphic DNA. The capacity of the probes Cg6 and Cg12 to assess microevolution in clonal populations of infecting C. glabrata over time is also demonstrated. These probes can now be used in large computer-assisted epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9421899     DOI: 10.1099/00221287-143-12-3733

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  30 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Genetic diversity among clinical isolates of Candida glabrata analyzed by randomly amplified polymorphic DNA and multilocus enzyme electrophoresis analyses.

Authors:  Xavier M Boldo; Lourdes Villa-Tanaca; Gerardo Zúñiga; César Hernández-Rodríguez
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

3.  Phenotypic switching in Candida glabrata involves phase-specific regulation of the metallothionein gene MT-II and the newly discovered hemolysin gene HLP.

Authors:  S A Lachke; T Srikantha; L K Tsai; K Daniels; D R Soll
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.

Authors:  Annemarie Borst; Maria T Raimer; David W Warnock; Christine J Morrison; Beth A Arthington-Skaggs
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  Characterization of switch phenotypes in Candida albicans biofilms.

Authors:  Y Jin; Y H Samaranayake; H K Yip; L P Samaranayake
Journal:  Mycopathologia       Date:  2005-10       Impact factor: 2.574

Review 6.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

7.  Cloning and characterization of a complex DNA fingerprinting probe for Candida parapsilosis.

Authors:  L Enger; S Joly; C Pujol; P Simonson; M Pfaller; D R Soll
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

8.  Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo.

Authors:  Sarah F Gee; Sophie Joly; David R Soll; Jacques F G M Meis; Paul E Verweij; Itzhack Polacheck; Derek J Sullivan; David C Coleman
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

9.  Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates.

Authors:  M A Pfaller; S R Lockhart; C Pujol; J A Swails-Wenger; S A Messer; M B Edmond; R N Jones; R P Wenzel; D R Soll
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Multilocus sequence typing of Candida glabrata reveals geographically enriched clades.

Authors:  Andrew R Dodgson; Claude Pujol; David W Denning; David R Soll; Andrew J Fox
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.